What is LOPJLB’s current signal on MCRB?

LOPJLB’s latest quantitative signal on Seres Therapeutics, Inc. (MCRB) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is MCRB in?

Seres Therapeutics, Inc. (MCRB) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Seres Therapeutics, Inc. (MCRB) do?

Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further en…

Where is Seres Therapeutics, Inc. based / listed?

Seres Therapeutics, Inc. is based in US, listed on NASDAQ.

Seres Therapeutics, Inc. (MCRB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.63-3.31%Close

SELLCRISIS · day 21

[SCORES & PROFILE]

FUND: 0
VALUE: 2
GROWTH: 11
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-36.2%

REV YoY-

ROE-60.3%

EPS YoY-

ROA-22.1%

GROSS

-4463

NET

-1193

[VALUATION]

P/E TTM-1.20

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B0.81

P/FCF-

EV/EBITDA-1.56

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E164.02

ALTMAN Z-

CURR RATIO2.11

ND/EBITDA-

BETA0.21

Seres Therapeutics, Inc. (MCRB)

Key stats

Prediction markets

FUNDAMENTALS

Company news